TGFB1 and ovarian cancer: In addition, their results showed that TGF-β1 in CAF-derived exosomes propels ovarian cancer cells to a more aggressive phenotype, proving that it could be a potential treatment in ovarian cancer targeting CAF-derived exosomes.